Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00IPP
|
|||
Former ID |
DNC013246
|
|||
Drug Name |
L-valyl-L-prolinamide
|
|||
Synonyms |
CHEMBL375933; 76362-52-2; L-valyl-L-prolinamide; L-Prolinamide, L-valyl-; CTK2G7856; DTXSID40469490
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C10H19N3O2
|
|||
Canonical SMILES |
CC(C)C(C(=O)N1CCCC1C(=O)N)N
|
|||
InChI |
1S/C10H19N3O2/c1-6(2)8(11)10(15)13-5-3-4-7(13)9(12)14/h6-8H,3-5,11H2,1-2H3,(H2,12,14)/t7-,8-/m0/s1
|
|||
InChIKey |
AGVCUVJROUBIKP-YUMQZZPRSA-N
|
|||
CAS Number |
CAS 76362-52-2
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Tripeptidyl-peptidase II (TPP2) | Target Info | Inhibitor | [1] |
Reactome | Antigen processing: Ubiquitination & Proteasome degradation |
References | Top | |||
---|---|---|---|---|
REF 1 | Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach ... J Med Chem. 2005 Nov 17;48(23):7333-42. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.